About Biorce
Biorce is a health technology company that has developed Aika, the first AI-native platform designed to accelerate the clinical trials lifecycle. Founded by Pedro Coelho after his father's terminal diagnosis revealed how inefficient processes delay life-saving treatments, Biorce's mission is to make clinical trials faster, smarter, and fully transparent. Aika unifies solutions for protocol design, feasibility assessment, and regulatory planning in one intuitive, conversational workspace. Unlike traditional black-box AI systems, Aika provides 100% explainable recommendations by cross-referencing approximately one million real clinical trials to identify proven patterns and best practices. The platform enables clinical teams to create protocol first drafts in 2 days instead of 21, complete submission-ready protocols in under 30 days versus 90, and reduce avoidable amendments by 60%. Aika's conversational interface requires no programming expertise, making it accessible to clinicians and trial managers. The platform is GxP-aligned, SOC2 Type II certified, and HIPAA-ready. Biorce serves pharmaceutical companies, biotechnology firms, and contract research organizations (CROs) across the US, EU, and APAC regions. Built by former CRO professionals, clinicians, regulatory experts, and AI leaders, the company has raised $52 million from DST Global and Norrsken VC to reinvent how clinical trials are designed and executed.
Mission & Story
Mission
To accelerate access to life-saving treatments by making clinical trials faster, smarter and fully transparent
Founding Story
Pedro Coelho founded Biorce after his father received a terminal diagnosis. While promising treatments existed, they would take years to reach patients—years his father didn't have. Fighting the system to extend his father's life, Pedro discovered that the enemy wasn't just the disease, but the time lost to inefficient processes that kept life-saving treatments from reaching people who need them most. This revelation became the company's founding principle: every day cut from clinical development is a day of life for someone waiting.
Who It Serves
Milestones & Awards
Recent Milestones
Raised $52 million from DST Global and Norrsken VC. Platform being used across US, EU, and APAC by global clinical trial teams. Published transparency report on explainable AI approach.
Awards & Recognition
Backed by DST Global (described as Europe's leading impact VC)
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Clario
Clario provides digital endpoint technology and evidence generation solutions for clinical trials. The company offers cardiac safety, eCOA, medical imaging, precision motion, and respiratory solutions to pharmaceutical, biotech, and CRO clients across all trial phases.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.